Genetically Determined Smoking Behavior and Risk of Nontraumatic Subarachnoid Hemorrhage
- 14 January 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 52 (2), 582-587
- https://doi.org/10.1161/strokeaha.120.031622
Abstract
Background and Purpose: Animal and observational studies indicate that smoking is a risk factor for aneurysm formation and rupture, leading to nontraumatic subarachnoid hemorrhage (SAH). However, a definitive causal relationship between smoking and the risk of SAH has not been established. Using Mendelian randomization (MR) analyses, we tested the hypothesis that smoking is causally linked to the risk of SAH. Methods: We conducted a 1-sample MR study using data from the UK Biobank, a large cohort study that enrolled over 500 000 Britons aged 40 to 69 from 2006 to 2010. Participants of European descent were included. SAH cases were ascertained using a combination of self-reported, electronic medical record, and death registry data. As the instrument, we built a polygenic risk score using independent genetic variants known to associate (P×10−8) with smoking behavior. This polygenic risk score represents the genetic susceptibility to smoking initiation. The primary MR analysis utilized the ratio method. Secondary MR analyses included the inverse variance weighted and weighted median methods. Results: A total of 408 609 study participants were evaluated (mean age, 57 [SD 8], female sex, 220 937 [54%]). Among these, 132 566 (32%) ever smoked regularly, and 904 (0.22%) had a SAH. Each additional SD of the smoking polygenic risk score was associated with 21% increased risk of smoking (odds ratio [OR], 1.21 [95% CI, 1.20–1.21]; PP=0.006). In the primary MR analysis, genetic susceptibility to smoking was associated with a 63% increase in the risk of SAH (OR, 1.63 [95% CI, 1.15–2.31]; P=0.006). Secondary analyses using the inverse variance weighted method (OR, 1.57 [95% CI, 1.13–2.17]; P=0.007) and the weighted median method (OR, 1.74 [95% CI, 1.06–2.86]; P=0.03) yielded similar results. There was no significant pleiotropy (MR-Egger intercept P=0.39; MR Pleiotropy Residual Sum and Outlier global test P=0.69). Conclusions: These findings provide evidence for a causal link between smoking and the risk of SAH. Download figure Download PowerPointThis publication has 26 references indexed in Scilit:
- Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panelNature Communications, 2015
- Population-specific genotype imputations using minimac or IMPUTE2Nature Protocols, 2015
- Second-generation PLINK: rising to the challenge of larger and richer datasetsGigaScience, 2015
- Lifelong Rupture Risk of Intracranial Aneurysms Depends on Risk FactorsStroke, 2014
- Modifiable Risk Factors for Aneurysmal Subarachnoid HemorrhageStroke, 2013
- Cigarette Smoke and Inflammation: Role in Cerebral Aneurysm Formation and RuptureMediators of Inflammation, 2012
- Impact of smoking cessation on the risk of subarachnoid haemorrhage: a nationwide multicentre case control studyJournal of Neurology, Neurosurgery & Psychiatry, 2012
- A map of human genome variation from population-scale sequencingNature, 2010
- Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage.Stroke, 1993
- Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study.Stroke, 1986